These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 37986699)
21. Validation Study of the MDS Criteria for the Diagnosis of Multiple System Atrophy in the Mayo Clinic Brain Bank. Sekiya H; Koga S; Murakami A; Kawazoe M; Kim M; Martin NB; Uitti RJ; Cheshire WP; Wszolek ZK; Dickson DW Neurology; 2023 Dec; 101(24):e2460-e2471. PubMed ID: 37816641 [TBL] [Abstract][Full Text] [Related]
22. Minimal change multiple system atrophy: an aggressive variant? Ling H; Asi YT; Petrovic IN; Ahmed Z; Prashanth LK; Hazrati LN; Nishizawa M; Ozawa T; Lang A; Lees AJ; Revesz T; Holton JL Mov Disord; 2015 Jun; 30(7):960-7. PubMed ID: 25854893 [TBL] [Abstract][Full Text] [Related]
23. Regional Overlap of Pathologies in Lewy Body Disorders. Colom-Cadena M; Grau-Rivera O; Planellas L; Cerquera C; Morenas E; Helgueta S; Muñoz L; Kulisevsky J; Martí MJ; Tolosa E; Clarimon J; Lleó A; Gelpi E J Neuropathol Exp Neurol; 2017 Mar; 76(3):216-224. PubMed ID: 28395086 [TBL] [Abstract][Full Text] [Related]
24. Natural history of multiple system atrophy in the USA: a prospective cohort study. Low PA; Reich SG; Jankovic J; Shults CW; Stern MB; Novak P; Tanner CM; Gilman S; Marshall FJ; Wooten F; Racette B; Chelimsky T; Singer W; Sletten DM; Sandroni P; Mandrekar J Lancet Neurol; 2015 Jul; 14(7):710-9. PubMed ID: 26025783 [TBL] [Abstract][Full Text] [Related]
25. Clinical and pathological characteristics of later onset multiple system atrophy. Sekiya H; Koga S; Otsuka Y; Chihara N; Ueda T; Sekiguchi K; Yoneda Y; Kageyama Y; Matsumoto R; Dickson DW J Neurol; 2022 Aug; 269(8):4310-4321. PubMed ID: 35305144 [TBL] [Abstract][Full Text] [Related]
26. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis. Irwin DJ; Grossman M; Weintraub D; Hurtig HI; Duda JE; Xie SX; Lee EB; Van Deerlin VM; Lopez OL; Kofler JK; Nelson PT; Jicha GA; Woltjer R; Quinn JF; Kaye J; Leverenz JB; Tsuang D; Longfellow K; Yearout D; Kukull W; Keene CD; Montine TJ; Zabetian CP; Trojanowski JQ Lancet Neurol; 2017 Jan; 16(1):55-65. PubMed ID: 27979356 [TBL] [Abstract][Full Text] [Related]
27. Copathology in Progressive Supranuclear Palsy: Does It Matter? Jecmenica Lukic M; Kurz C; Respondek G; Grau-Rivera O; Compta Y; Gelpi E; Troakes C; ; van Swieten JC; Giese A; Roeber S; Arzberger T; Höglinger G Mov Disord; 2020 Jun; 35(6):984-993. PubMed ID: 32125724 [TBL] [Abstract][Full Text] [Related]
28. A Questionnaire-Based Study on Clinical REM Sleep Behavior Disorder and Subtypes in Multiple System Atrophy. Wu DD; Su W; Li SH; He J; Li K; Chen HB; Jin Y Eur Neurol; 2021; 84(5):368-374. PubMed ID: 34134116 [TBL] [Abstract][Full Text] [Related]
29. Neuropathological correlates of parkinsonian disorders in a large Dutch autopsy series. Geut H; Hepp DH; Foncke E; Berendse HW; Rozemuller JM; Huitinga I; van de Berg WDJ Acta Neuropathol Commun; 2020 Mar; 8(1):39. PubMed ID: 32216828 [TBL] [Abstract][Full Text] [Related]
30. GBA variation and susceptibility to multiple system atrophy. Wernick AI; Walton RL; Koga S; Soto-Beasley AI; Heckman MG; Gan-Or Z; Ren Y; Rademakers R; Uitti RJ; Wszolek ZK; Cheshire WP; Dickson DW; Ross OA Parkinsonism Relat Disord; 2020 Aug; 77():64-69. PubMed ID: 32623306 [TBL] [Abstract][Full Text] [Related]
31. Fluorescence and autoradiographic evaluation of tau PET ligand PBB3 to α-synuclein pathology. Koga S; Ono M; Sahara N; Higuchi M; Dickson DW Mov Disord; 2017 Jun; 32(6):884-892. PubMed ID: 28440890 [TBL] [Abstract][Full Text] [Related]
32. Incidence and prevalence of multiple system atrophy: a nationwide study in Iceland. Bjornsdottir A; Gudmundsson G; Blondal H; Olafsson E J Neurol Neurosurg Psychiatry; 2013 Feb; 84(2):136-40. PubMed ID: 23192520 [TBL] [Abstract][Full Text] [Related]
33. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study. Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042 [TBL] [Abstract][Full Text] [Related]
35. Pan-American Consortium of Multiple System Atrophy (PANMSA). A Pan-American multicentre cohort study of multiple system atrophy. Gatto E; Rodríguez-Violante M; Cosentino C; Chana-Cuevas P; Miranda M; Gallin E; Etcheverry JL; Nuñez Y; Parisi V; Persi G; Vecchi C; Sanguinetti A; Alleva A; Aparcana J; Torres L; Litvan I J Parkinsons Dis; 2014; 4(4):693-8. PubMed ID: 25213997 [TBL] [Abstract][Full Text] [Related]
36. Recent advances in neuropathology, biomarkers and therapeutic approach of multiple system atrophy. Koga S; Dickson DW J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):175-184. PubMed ID: 28860330 [TBL] [Abstract][Full Text] [Related]
37. Profile of multiple system atrophy in Moroccan patients attending a movement disorders outpatient clinic in Rabat university hospital. Regragui W; Lachhab L; Razine R; Benjelloun H; Ait Benhaddou EH; Benomar A; Yahyaoui M Rev Neurol (Paris); 2013 Feb; 169(2):121-5. PubMed ID: 22763206 [TBL] [Abstract][Full Text] [Related]
38. A Histologic Study of the Circadian System in Parkinson Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy. De Pablo-Fernández E; Courtney R; Warner TT; Holton JL JAMA Neurol; 2018 Aug; 75(8):1008-1012. PubMed ID: 29710120 [TBL] [Abstract][Full Text] [Related]
39. Anhidrosis in multiple system atrophy involves pre- and postganglionic sudomotor dysfunction. Coon EA; Fealey RD; Sletten DM; Mandrekar JN; Benarroch EE; Sandroni P; Low PA; Singer W Mov Disord; 2017 Mar; 32(3):397-404. PubMed ID: 27859565 [TBL] [Abstract][Full Text] [Related]